investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of Meiotic Recombination

Michael Lichten

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Alastair Goldman

University of Sheffield

Sheffield, United Kingdom

Related projects

Gordon B. Mills

Biological annotation of TCGA data

All cancers but non-melanoma skin cancer

Terrence Burke

Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs

All cancers but non-melanoma skin cancer

Sharon Y. R. Dent

Defining USP22 Functions During Mammalian Development

All cancers but non-melanoma skin cancer

Nicholas E Baker

Neuronal Cell Cycle and Survival

All cancers but non-melanoma skin cancer

Leslie Eric Silberstein

Transfusion Biology and Cellular Therapies

All cancers but non-melanoma skin cancer

Hematology and hematologic malignancies

Yves Pommier

Pharmacology of HIV Viral DNA and Retroviral Integrases

All cancers but non-melanoma skin cancer

Byungkook Lee

Computational Biology

All cancers but non-melanoma skin cancer

Gregory A Lizee

Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs

All cancers but non-melanoma skin cancer

Ira Pastan

Development of Improved Mesothelin Targeted Immunotoxins and other Tumor Specific Targeted Immunotoxins Using Proprietary Targeting Moieties

All cancers but non-melanoma skin cancer